Iloprost for Bridging to Heart Transplantation in PH

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2015

Primary Completion Date

March 17, 2015

Study Completion Date

March 17, 2015

Conditions
Chronic Left Ventricular FailurePulmonary Hypertension
Interventions
DRUG

Inhaled Iloprost

Treatment effect will be controlled at each study visit and the dose and/or inhalation frequency will be adapted.

DRUG

Placebo

inhalation solution placebo

Trial Locations (2)

32545

Klinik für Thorax- und Kardiovaskularchirurgie, Bad Oeynhausen

69126

Thoraxclinic at the University of Heidelberg, Heidelberg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Heidelberg University

OTHER